Q-State Biosciences
Caitlin Lewarch began their work experience in 2011 as a Graduate Student Researcher at Harvard University, where they worked until 2019. During their time at Harvard, they also served as a Teaching Fellow from 2013. In 2019, Caitlin joined Insight Data Science as a Fellow for a brief period of time. Later that year, they transitioned to Q-State Biosciences as a Data Scientist, a role they held until 2020. Caitlin then advanced to the position of Senior Bioinformatics Scientist at Q-State Biosciences in 2021.
Caitlin Lewarch completed their education with a Bachelor of Arts degree in Human Evolutionary Biology from Harvard University in 2010. Caitlin further pursued their academic journey at the same institution and obtained a Doctor of Philosophy degree in Biology in 2019.
Q-State Biosciences
Q-State Biosciences is a technology-derived medicines company based in Cambridge, MA, that combines advanced human cellular models, unique measurement engineering, and AI/machine learning into a proprietary platform that enables novel discovery of optimized genetically targeted medicines for epilepsy, pain, and other diseases of the CNS.